Health care pharmaceutical companies by P/S ratio
Market value divided by the latest fiscal year's revenue: what the market pays for each dollar of sales.
Grifols has the lowest figure of the 50 health care pharmaceutical companies ranked by P/S ratio, at 0.7, followed by Viatris (1.6) and GSK (2.2). Figures as of 20 Nov 2026, 03:36 UTC, from Yahoo Finance quotes.
Key facts
- Companies ranked
- 50
- Lowest
- Grifols0.7
- Median
- 6.7
- Combined market value
- DKK 33.79T
- Countries
- 10
- Not ranked
- 11no P/S ratio on file
Market values as of .
All countries▾
Health Care▾
Pharmaceuticals▾
| # | Company | P/S ↑ | Market cap | Price | Today | 1 year | Price, 30 days | Country |
|---|---|---|---|---|---|---|---|---|
| 1 | GrifolsGRFS · Health Care | 0.7 | DKK 38B | DKK 55.84 | 3.19% down | 0% up | ||
| 2 | ViatrisVTRS · Health Care | 1.6 | DKK 155.2B | DKK 135.37 | 1.97% down | 99% up | ||
| 3 | GSKGSK · Health Care | 2.2 | DKK 652.7B | DKK 325.63 | 1.56% down | 5% up | ||
| 4 | SanofiSNY · Health Care | 2.3 | DKK 753.1B | DKK 313.64 | 2.25% down | 4% down | ||
| 5 | Takeda PharmaceuticalTAK · Health Care | 2.4 | DKK 465.8B | DKK 145.79 | 0.66% up | 51% up | ||
| 6 | Amneal PharmaceuticalsAMRX · Health Care | 2.5 | DKK 50.7B | DKK 145.65 | 2.24% down | 90% up | ||
| 7 | Bristol-Myers SquibbBMY · Health Care | 2.5 | DKK 812B | DKK 397.26 | 2.05% down | 30% up | ||
| 8 | PfizerPFE · Health Care | 2.5 | DKK 1.07T | DKK 187.53 | 1.85% down | 15% up | ||
| 9 | Teva Pharmaceutical IndustriesTEVA · Health Care | 2.6 | DKK 306.2B | DKK 262.44 | 8.74% down | 74% up | ||
| 10 | Elanco Animal HealthELAN · Health Care | 2.8 | DKK 89.5B | DKK 179.02 | 1.54% down | 26% up | ||
| 11 | PTC TherapeuticsPTCT · Health Care | 2.8 | DKK 33.2B | DKK 397.16 | 3.16% down | 21% down | ||
| 12 | Legend BiotechLEGN · Health Care | 3.0 | DKK 21.3B | DKK 109.63 | 0.92% down | 41% down | ||
| 13 | Dr. Reddy's LaboratoriesRDY · Health Care | 3.5 | DKK 84.2B | DKK 100.98 | 1.00% down | 8% up | ||
| 14 | ZoetisZTS · Health Care | 3.5 | DKK 223.5B | DKK 550.14 | 5.59% down | 26% down | ||
| 15 | Jazz PharmaceuticalsJAZZ · Health Care | 3.6 | DKK 103.4B | DKK 1,610.10 | 4.57% down | 41% up | ||
| 16 | BioMarin PharmaceuticalBMRN · Health Care | 3.7 | DKK 81B | DKK 418.24 | 0.02% down | 17% up | ||
| 17 | Novo NordiskNVO · Health Care | 3.7 | DKK 1.17T | DKK 264.68 | 1.42% down | 17% down | ||
| 18 | Abbott LaboratoriesABT · Health Care | 4.1 | DKK 1.22T | DKK 707.30 | 0.58% down | 16% down | ||
| 19 | AstraZenecaAZN · Health Care | 4.6 | DKK 1.85T | DKK 1,194.45 | 1.87% down | 1% up | ||
| 20 | Ionis PharmaceuticalsIONS · Health Care | 4.8 | DKK 30.9B | DKK 185.35 | 0.62% down | 63% down | ||
| 21 | Merck & CoMRK · Health Care | 5.0 | DKK 2.23T | DKK 904.36 | 3.61% down | 45% up | ||
| 22 | NovartisNVS · Health Care | 5.2 | DKK 1.94T | DKK 1,029.73 | 2.57% down | 25% up | ||
| 23 | AlkermesALKS · Health Care | 5.3 | DKK 52.8B | DKK 314.46 | 1.43% down | 66% up | ||
| 24 | Alnylam PharmaceuticalsALNY · Health Care | 5.3 | DKK 134.8B | DKK 1,006.57 | 1.06% down | 66% down | ||
| 25 | Regeneron PharmaceuticalsREGN · Health Care | 6.7 | DKK 650.4B | DKK 6,287.45 | 2.35% down | 28% up | ||
| 26 | Johnson & JohnsonJNJ · Health Care | 6.8 | DKK 4.38T | DKK 1,819.08 | 2.04% down | 34% up | ||
| 27 | Arrowhead PharmaceuticalsARWR · Health Care | 7.4 | DKK 42B | DKK 297.23 | 1.25% up | 13% up | ||
| 28 | United TherapeuticsUTHR · Health Care | 7.5 | DKK 162.1B | DKK 3,807.17 | 3.16% down | 22% up | ||
| 29 | AbbVieABBV · Health Care | 8.2 | DKK 3.41T | DKK 1,930.75 | 0.86% down | 25% up | ||
| 30 | GenmabGMAB · Health Care | 8.5 | DKK 215.6B | DKK 349.67 | 0.75% up | 70% up | ||
| 31 | BeOne MedicinesONC · Health Care | 8.5 | DKK 310.9B | DKK 2,721.74 | 0.97% down | 16% up | ||
| 32 | Corcept TherapeuticsCORT · Health Care | 9.3 | DKK 48.4B | DKK 442.48 | 4.15% down | 10% down | ||
| 33 | Travere TherapeuticsTVTX · Health Care | 9.4 | DKK 31.6B | DKK 328.90 | 3.86% down | 45% up | ||
| 34 | Madrigal PharmaceuticalsMDGL · Health Care | 9.6 | DKK 62.8B | DKK 2,701.59 | 0.34% down | 27% down | ||
| 35 | Kiniksa Pharmaceuticals InternationalKNSA · Health Care | 10.8 | DKK 50B | DKK 636.92 | 1.59% down | 129% up | ||
| 36 | Vertex PharmaceuticalsVRTX · Health Care | 11.0 | DKK 898.9B | DKK 3,545.41 | 2.94% down | 27% up | ||
| 37 | Axsome TherapeuticsAXSM · Health Care | 11.2 | DKK 48.6B | DKK 923.91 | 1.25% up | 6% down | ||
| 38 | Mirum PharmaceuticalsMIRM · Health Care | 12.0 | DKK 42.5B | DKK 650.37 | 3.27% up | 34% up | ||
| 39 | TG TherapeuticsTGTX · Health Care | 15.9 | DKK 66.8B | DKK 441.80 | 1.88% down | 117% up | ||
| 40 | Royalty PharmaRPRX · Health Care | 16.4 | DKK 265.1B | DKK 461.14 | 1.38% down | 79% up | ||
| 41 | Eli LillyLLY · Health Care | 18.5 | DKK 8.2T | DKK 9,200.40 | 2.29% down | 33% up | ||
| 42 | Ascendis PharmaASND · Health Care | 21.0 | DKK 114.3B | DKK 1,742.95 | 5.32% down | 29% up | ||
| 43 | Ligand PharmaceuticalsLGND · Health Care | 21.4 | DKK 39.1B | DKK 1,953.91 | 3.94% down | 50% up | ||
| 44 | BridgeBio PharmaBBIO · Health Care | 30.3 | DKK 103.7B | DKK 532.36 | 0.22% up | 21% up | ||
| 45 | Rhythm PharmaceuticalsRYTM · Health Care | 42.7 | DKK 55.1B | DKK 795.34 | 1.88% down | 18% up | ||
| 46 | InsmedINSM · Health Care | 52.3 | DKK 215.8B | DKK 983.69 | 20.58% up | 40% down | ||
| 47 | CytokineticsCYTK · Health Care | 81.4 | DKK 48.8B | DKK 350.41 | 0.27% up | 19% down | ||
| 48 | Protagonist TherapeuticsPTGX · Health Care | 176 | DKK 55.1B | DKK 844.51 | 2.47% down | 51% up | ||
| 49 | Dianthus TherapeuticsDNTH · Health Care | 2346 | DKK 32.5B | DKK 577.65 | 1.01% up | 108% up | ||
| 50 | Roivant SciencesROIV · Health Care | 3418 | DKK 192.2B | DKK 265.30 | 0.59% up | 91% up |
Sources: share prices and market values from Yahoo Finance; sector, country and category from each company's SEC registration.
Market value is share price × shares outstanding, from Yahoo Finance; prices may be delayed 15 minutes or more and the ranking refreshes about every 20 minutes. The list covers companies with shares listed in the US, which includes foreign companies listed through ADRs but not ones listed only abroad. Sector, category and country come from each company's SEC registration. P/S divides today's market value by the latest fiscal year's revenue from the annual report. Sums are converted from US dollars at today's exchange rate (1 USD = 6.8095 DKK). 11 companies have no P/S ratio on file and are not ranked here.
Questions and answers
Which health care pharmaceutical companies have the lowest P/S ratio?
Grifols (0.7), Viatris (1.6) and GSK (2.2) have the lowest P/S ratio of the 50 health care pharmaceutical companies ranked here as of 20 Nov 2026, 03:36 UTC.
How many health care pharmaceutical companies are in this ranking?
50 are ranked by P/S ratio. 11 more have no P/S ratio on file and are left out rather than ranked at zero.
What are these health care pharmaceutical companies worth together?
The 50 health care pharmaceutical companies ranked by P/S ratio have a combined market value of DKK 33.79T as of 20 Nov 2026, 03:36 UTC.
What does ranking by P/S ratio measure?
Market value divided by the latest fiscal year's revenue: what the market pays for each dollar of sales.
Learn how this ranking works
All markets guides →- P/E ratio explained: what a high or low figure means
The price-to-earnings (P/E) ratio is a share's price divided by its earnings per share. A stock at $100 earning $5 a share has a P/E of 20: buyers pay $20 for each dollar of yearly profit. A high P/E usually means the market expects profit to grow; a low one can mean doubt, not a bargain.
- Revenue vs earnings vs free cash flow: what each tells you
Revenue is everything a company sold in a period. Earnings, or net income, is what remains after every cost, interest and tax. Free cash flow is the cash operations brought in minus spending on long-lived assets. Revenue shows size and demand, earnings show profitability, and free cash flow shows how much cash the business can actually hand out.
- How an ETF's size is measured: AUM, NAV and creation units
An ETF's size is usually measured by its assets under management (AUM), the fund's net assets: everything it holds minus what it owes. That equals net asset value per share times shares outstanding. AUM grows when the holdings rise in value and when large institutions create new shares, and shrinks when they redeem them.
Cite this page
Funkfolio, “Health care pharmaceutical companies by P/S ratio”, data as of 20 November 2026. https://funkfolio.com/companies/category/pharmaceuticals?sector=health-care&by=ps-ratio
Underlying data: Yahoo Finance; SEC EDGAR.